(Q37763102)

22 August 2017

1 reference

title

DNA amplifications in breast cancer: genotypic-phenotypic correlations (English)

1 reference

22 August 2017

1 reference

5

Jorge S Reis-Filho

1 reference

22 August 2017

4

Alan Ashworth

1 reference

22 August 2017

2

Rachael Natrajan

1 reference

22 August 2017

3

Felipe C Geyer

1 reference

22 August 2017

1

Kai-Keen Shiu

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

6

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

967-984

1 reference

Gene-expression signatures in breast cancer

22 August 2017

cites work

1 reference

The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

21 January 2018

1 reference

Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma

21 January 2018

1 reference

21 January 2018

1 reference

A census of amplified and overexpressed human cancer genes

21 January 2018

1 reference

Molecular evolution of breast cancer

21 January 2018

1 reference

Integrated profiling of basal and luminal breast cancers.

21 January 2018

1 reference

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

21 January 2018

1 reference

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

21 January 2018

1 reference

High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer

21 January 2018

1 reference

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.

21 January 2018

1 reference

Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?

21 January 2018

1 reference

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

21 January 2018

1 reference

An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

21 January 2018

1 reference

Complex landscapes of somatic rearrangement in human breast cancer genomes

21 January 2018

1 reference

Gene amplification in cancer

21 January 2018

1 reference

Mechanisms of change in gene copy number

21 January 2018

1 reference

Intermingling of chromosome territories in interphase suggests role in translocations and transcription-dependent associations

21 January 2018

1 reference

Genetic characterization of breast cancer and implications for clinical management

21 January 2018

1 reference

Histological and molecular types of breast cancer: is there a unifying taxonomy?

21 January 2018

1 reference

Genome-wide functional synergy between amplified and mutated genes in human breast cancer

21 January 2018

1 reference

Resolving the resolution of array CGH.

21 January 2018

1 reference

Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research

21 January 2018

1 reference

The pitfalls of platform comparison: DNA copy number array technologies assessed

21 January 2018

1 reference

Genome position and gene amplification

21 January 2018

1 reference

Breast tumor copy number aberration phenotypes and genomic instability

21 January 2018

1 reference

Novel patterns of genome rearrangement and their association with survival in breast cancer

21 January 2018

1 reference

A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines

21 January 2018

1 reference

Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes

21 January 2018

1 reference

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH.

21 January 2018

1 reference

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast

21 January 2018

1 reference

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

21 January 2018

1 reference

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

21 January 2018

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

21 January 2018

1 reference

Molecular classification of breast cancer: limitations and potential

21 January 2018

1 reference

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

21 January 2018

1 reference

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response

21 January 2018

1 reference

Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.

21 January 2018

1 reference

Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis

21 January 2018

1 reference

High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.

21 January 2018

1 reference

Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family

21 January 2018

1 reference

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

21 January 2018

1 reference

Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery

21 January 2018

1 reference

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis

21 January 2018

1 reference

Comprehensive profiling of 8p11-12 amplification in breast cancer

21 January 2018

1 reference

Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer

21 January 2018

1 reference

FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas

21 January 2018

1 reference

Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer

21 January 2018

1 reference

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

21 January 2018

1 reference

CDK-independent activation of estrogen receptor by cyclin D1

21 January 2018

1 reference

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome

21 January 2018

1 reference

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis

21 January 2018

1 reference

Cyclin D1 is necessary for tamoxifen-induced cell cycle progression in human breast cancer cells

21 January 2018

1 reference

Cyclin D1, EMS1 and 11q13 amplification in breast cancer

21 January 2018

1 reference

Focal amplification and oncogene dependency of GAB2 in breast cancer

21 January 2018

1 reference

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

21 January 2018

1 reference

Biological determinants of endocrine resistance in breast cancer

21 January 2018

1 reference

PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer

21 January 2018

1 reference

Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.

21 January 2018

1 reference

ESR1 gene amplification in breast cancer: a common phenomenon?

21 January 2018

1 reference

ESR1 amplification in endometrial carcinomas: hope or hyperbole?

21 January 2018

1 reference

DNA copy number alterations and expression of relevant genes in triple-negative breast cancer

21 January 2018

1 reference

Basal-like breast cancer: a critical review

21 January 2018

1 reference

Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probes.

21 January 2018

1 reference

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

21 January 2018

1 reference

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics

21 January 2018

1 reference

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

21 January 2018

1 reference

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

21 January 2018

1 reference

Subtypes of breast cancer show preferential site of relapse

21 January 2018

1 reference

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

21 January 2018

1 reference

Refinement of breast cancer classification by molecular characterization of histological special types

21 January 2018

1 reference

Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis

21 January 2018

1 reference

Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum

21 January 2018

1 reference

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

Are triple-negative tumours and basal-like breast cancer synonymous?

21 January 2018

1 reference

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

21 January 2018

1 reference

How basal are triple-negative breast cancers?

21 January 2018

1 reference

BRCA1 dysfunction in sporadic basal-like breast cancer

21 January 2018

1 reference

A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair

21 January 2018

1 reference

Integrated functional, gene expression and genomic analysis for the identification of cancer targets

21 January 2018

1 reference

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

21 January 2018

1 reference

EGFR associated expression profiles vary with breast tumor subtype

21 January 2018

1 reference

Basal-like breast cancer and the BRCA1 phenotype

21 January 2018

1 reference

EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

21 January 2018

1 reference

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

21 January 2018

1 reference

Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer

21 January 2018

1 reference

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells

21 January 2018

1 reference

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

21 January 2018

1 reference

Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer

21 January 2018

1 reference

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

The genomic profile of HER2-amplified breast cancers: the influence of ER status

21 January 2018

1 reference

Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes

21 January 2018

1 reference

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

21 January 2018

1 reference

Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer

21 January 2018

1 reference

HER-2 and topoisomerase II as predictors of response to chemotherapy

21 January 2018

1 reference

Are HER2 and TOP2A useful as prognostic or predictive biomarkers for anthracycline-based adjuvant chemotherapy for breast cancer?

21 January 2018

1 reference

Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601).

21 January 2018

1 reference

Alterations in the TOP2A and HER2 genes: association with adjuvant anthracycline sensitivity in human breast cancers

21 January 2018

1 reference

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

21 January 2018

1 reference

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

21 January 2018

1 reference

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer

21 January 2018

1 reference

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

21 January 2018

1 reference

Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer.

21 January 2018

1 reference

Trastuzumab: triumphs and tribulations

21 January 2018

1 reference

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

21 January 2018

1 reference

Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study.

21 January 2018

1 reference

Gene copy mapping of the ERBB2/TOP2A region in breast cancer

21 January 2018

1 reference

RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes

21 January 2018

1 reference

High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer

21 January 2018

1 reference

A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

21 January 2018

1 reference

Brk is coamplified with ErbB2 to promote proliferation in breast cancer

21 January 2018

1 reference

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

21 January 2018

1 reference

Next-generation sequencing.

21 January 2018

1 reference

Accurate whole human genome sequencing using reversible terminator chemistry

21 January 2018

1 reference

Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

21 January 2018

1 reference

Transcriptome sequencing to detect gene fusions in cancer

21 January 2018

1 reference

Chimeric transcript discovery by paired-end transcriptome sequencing

21 January 2018

1 reference

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

21 January 2018

1 reference

Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.

21 January 2018

1 reference

Utilizing RNA interference to enhance cancer drug discovery

21 January 2018

1 reference

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas

21 January 2018

1 reference

Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype

21 January 2018

1 reference

Resistance to therapy caused by intragenic deletion in BRCA2

21 January 2018

1 reference

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

21 January 2018

1 reference

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

21 January 2018

1 reference

NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis

21 January 2018

1 reference

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

21 January 2018

1 reference

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

21 January 2018

1 reference

Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/FON.10.56

1 reference

22 August 2017

1 reference